Skip to main content
Log in

The cell biology of the thyroid-disrupting mechanism of dichlorodiphenyltrichloroethane (DDT)

  • Short Review
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Objective

Dichlorodiphenyltrichloroethane (DDT) is an organochlorine known for its pesticide properties and for its negative effects on human health. It was banned in most countries for its toxicity to the endocrine system, but due to its persistence at clinically relevant concentrations in both soil and animal tissues, DDT is still linked to several health and social problems.

Methods

We have previously shown that DDT exposure is causally related to the extracellular release of vesicular organelles such as microvesicles and/or exosomes by using immunocytochemistry with gold-tagged antibodies and various fluorescent membrane markers.

Results

It is now well recognized that microvesicles and/or exosomes organelles are implicated in cell-to-cell communication, and that they are fundamental elements for transferring proteins, RNA, DNA, lipids and transcriptional factors among cells. In this short review, we discussed the role of extracellular vesicle formation in the thyroid-disrupting mechanism of DDT. In particular, we described how DDT, by dislodging the thyrotropin hormone (TSH) receptor from the raft containing compartments of the cells, prevents its activation and internalization.

Conclusion

Based on our earlier finding and on the large body of evidence here reviewed, we propose that DDT-induced formation of extracellular vesicles containing the TSH receptor could be directly involved in the development of autoimmune responses against the TSH receptor and that, therefore, their release could lead to the development of the Graves’ disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Coperchini F, Awwad O, Rotondi M, Santini F, Imbriani M, Chiovato L (2017) Thyroid disruption by perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA). J Endocrinol Invest 40:105–121

    Article  CAS  PubMed  Google Scholar 

  2. Metcalf RL (1973) A century of DDT. J Agric Food Chem 21:511–519

    Article  CAS  PubMed  Google Scholar 

  3. Tilghman SL, Bratton MR, Segar HC, Martin EC, Rhodes LV, Li M, McLachlan JA, Wiese TE, Nephew KP, Burow ME (2012) Endocrine disruptor regulation of microRNA expression in breast carcinoma cells. PLoS ONE 7:e32754

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Ibhazehiebo K, Koibuchi N (2014) Impact of endocrine-disrupting chemicals on thyroid function and brain development. Expert Rev Endocrinol Metab 9:579–591

    Article  CAS  Google Scholar 

  5. Brar NK, Waggoner C, Reyes JA, Fairey R, Kelley KM (2010) Evidence for thyroid endocrine disruption in wild fish in San Francisco Bay, California, USA. Relationships to contaminant exposures. Aquat Toxicol 96:203–215

    Article  CAS  PubMed  Google Scholar 

  6. Freire C, Koifman RJ, Sarcinelli PN, Rosa AC, Clapauch R, Koifman S (2014) Association between serum levels of organochlorine pesticides and sex hormones in adults living in a heavily contaminated area in Brazil. Int J Hyg Environ Health 217:370–378

    Article  CAS  PubMed  Google Scholar 

  7. Boas M, Feldt-Rasmussen U, Main KM (2012) Thyroid effects of endocrine disrupting chemicals. Mol Cell Endocrinol 355:240–248

    Article  CAS  PubMed  Google Scholar 

  8. Müller CE, Schiedel AC, Baqi Y (2012) Allosteric modulators of rhodopsin-like G protein-coupled receptors: opportunities in drug development. Pharmacol Ther 135:292–315

    Article  PubMed  Google Scholar 

  9. Gershengorn MC, Neumann S (2012) Update in TSH receptor agonists and antagonists. J Clin Endocrinol Metab 97:4287–4292

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Tschammer N (2016) Allosteric modulators of the class A G protein coupled receptors. Adv Exp Med Biol 917:185–207

    Article  CAS  PubMed  Google Scholar 

  11. Santini F, Vitti P, Ceccarini G, Mammoli C, Rosellini V, Pelosini C, Marsili A, Tonacchera M, Agretti P, Santoni T, Chiovato L, Pinchera A (2003) In vitro assay of thyroid disruptors affecting TSH-stimulated adenylate cyclase activity. J Endocrinol Invest 26:950–955

    Article  CAS  PubMed  Google Scholar 

  12. Rossi M, Dimida A, Dell’anno MT, Trincavelli ML, Agretti P, Giorgi F, Corsini GU, Pinchera A, Vitti P, Tonacchera M, Maggio R (2007) The thyroid disruptor 1,1,1-trichloro-2,2-bis(p-chlorophenyl)-ethane appears to be an uncompetitive inverse agonist for the thyrotropin receptor. J Pharmacol Exp Ther 320:465–474

    Article  CAS  PubMed  Google Scholar 

  13. Rossi M, Dimida A, Ferrarini E, Silvano E, De Marco G, Agretti P, Aloisi G, Simoncini T, Di Bari L, Tonacchera M, Giorgi F, Maggio R (2009) Presence of a putative steroidal allosteric site on glycoprotein hormone receptors. Eur J Pharmacol 623:155–159

    Article  CAS  PubMed  Google Scholar 

  14. De Gregorio F, Pellegrino M, Picchietti S, Belardinelli MC, Taddei AR, Fausto AM, Rossi M, Maggio R, Giorgi F (2011) The insecticide 1,1,1-trichloro-2,2-bis(p-chlorophenyl) ethane (DDT) alters the membrane raft location of the TSH receptor stably expressed in Chinese hamster ovary cells. Toxicol Appl Pharmacol 253:121–129

    Article  PubMed  Google Scholar 

  15. Calebiro D (2011) Thyroid-stimulating hormone receptor activity after internalization. Annales des Endocrinologie (Paris) 72:64–67

    Article  CAS  Google Scholar 

  16. Giorgi F, Auletta G (2016) Semiotic tools for multilevel cell communication. Biosemiotics 9:365–382

    Article  Google Scholar 

  17. Sellitti DF, Akamizu T, Doi SQ, Kim GH, Kariyil JT, Kopchik JJ, Koshiyama H (2000) Renal expression of two ‘thyroid-specific’ genes: thyrotropin receptor and thyroglobulin. Exp Nephrol 8:235-243

  18. Williams GR (2011) Extrathyroidal expression of TSH receptor. Ann Endocrinol (Paris) 72:68–73

    Article  CAS  Google Scholar 

  19. Pierce KL, Premont RT, Lefkowitz RJ (2002) Seven-transmembrane receptors. Nat Rev Mol Cell Biol 3:639–650

    Article  CAS  PubMed  Google Scholar 

  20. Allgeier A, Offermanns S, Van Sande J, Spicher K, Schultz G, Dumont JE (1994) The human thyrotropin receptor activates G-proteins Gs and Gq/11. J Biol Chem 269:13733–13735

    CAS  PubMed  Google Scholar 

  21. Couët J, de Bernard S, Loosfelt H, Saunier B, Milgrom E, Misrahi M (1996) Cell surface protein disulfide-isomerase is involved in the shedding of human thyrotropin receptor ectodomain. Biochemistry 35:14800–14805

    Article  PubMed  Google Scholar 

  22. Couët J, Sar S, Jolivet A, Hai MT, Milgrom E, Misrahi M (1996) Shedding of human thyrotropin receptor ectodomain. Involvement of a matrix metalloprotease. J Biol Chem 271:4545–4552

    Article  PubMed  Google Scholar 

  23. Misrahi M, Couet J, Milgrom E (1997) Mechanisms of shedding of a soluble form of the TSH receptor. Ann Endocrinol (Paris) 58:365–369

    CAS  Google Scholar 

  24. Latif R, Ando T, Davies TF (2004) Monomerization as a prerequisite for intramolecular cleavage and shedding of the thyrotropin receptor. Endocrinology 145:5580–5588

    Article  CAS  PubMed  Google Scholar 

  25. Maggio R, Innamorati G, Parenti M (2007) G protein-coupled receptor oligomerization provides the framework for signal discrimination. J Neurochem 103:1741–1752

    Article  CAS  PubMed  Google Scholar 

  26. Scarselli M, Annibale P, McCormick PJ, Kolachalam S, Aringhieri S, Radenovic A, Corsini GU, Maggio R (2016) Revealing G-protein-coupled receptor oligomerization at the single-molecule level through a nanoscopic lens: methods, dynamics and biological function. FEBS J 283:1197–1217

    Article  CAS  PubMed  Google Scholar 

  27. Giorgi F, Bruni LE, Maggio R (2010) Receptor oligomerization as a process modulating cellular semiotics. Biosemiotics 3:157–176

    Article  Google Scholar 

  28. Baratti-Elbaz C, Ghinea N, Lahuna O, Loosfelt H, Pichon C, Milgrom E (1999) Internalization and recycling pathways of the thyrotropin receptor. Mol Endocrinol 13:1751–1765

    Article  CAS  PubMed  Google Scholar 

  29. Singh SP, McDonald D, Hope TJ, Prabhakar BS (2004) Upon thyrotropin binding the thyrotropin receptor is internalized and localized to endosome. Endocrinology 145:1003–1010

    Article  CAS  PubMed  Google Scholar 

  30. Hoffmann C, Gaietta G, Bünemann M, Adams SR, Oberdorff-Maass S, Behr B, Vilardaga J-P, Tsien RY, Ellisman MH, Lohse MJ (2005) A FlAsH-based FRET approach to determine G protein—coupled receptor activation in living cells. Nat Methods 2:171–176

    Article  CAS  PubMed  Google Scholar 

  31. Picchietti S, Belardinelli M, Taddei AR, Fausto AM, Pellegrino M, Maggio R, Rossi M, Giorgi F (2009) Thyroid disruptor 1,1,1-trichloro-2,2-bis(p-chlorophenyl) ethane (DDT) prevents internalization of TSH receptor. Cell Tissue Research 336:31–40

    Article  CAS  PubMed  Google Scholar 

  32. Cornelia W, Ferguson SSG (2015) Minireview: role of intracellular scaffolding proteins in the regulation of endocrine G protein-coupled receptor signaling. Mol Endocrinol 29:814–830

    Article  Google Scholar 

  33. De Azua IR, Nakajima K-I, Rossi M, Cui Y, Jou W, Gavrilova O, Wess J (2012) Spinophilin as a novel regulator of M3 muscarinic receptor-mediated insulin release in vitro and in vivo. FASEB J 26:4275–4286

    Article  Google Scholar 

  34. Latif R, Ando T, Davies TF (2007) Lipid rafts are triage centers for multimeric and monomeric thyrotropin receptor regulation. Endocrinology 148:3164–3175

    Article  CAS  PubMed  Google Scholar 

  35. Del Conde I, Shrimpton CN, Thiagarajan P, López JA (2005) Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106:1604–1611

    Article  PubMed  Google Scholar 

  36. Baciu AE, Uyy E, Uică VI, Boteanu RM, Popescu AI, Giulea C, Manda D, Badiu C, Antohe F (2017) Proteomic analysis of plasma molecular markers as predictors of differentiated thyroid cancer. Rom Rep Phys 69:601

    Google Scholar 

  37. Muralidharan-Chari V, Clancy JW, Sedgwick A, D’Souza-Schorey C (2010) Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci 123:1603–1611

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Rodríguez-Muñoz A, Martínez-Hernández R, Ramos-Leví AM, Serrano-Somavilla A, González-Amaro R, Sánchez-Madrid F, de la Fuente H, Marazuela M (2015) Circulating microvesicles regulate treg and th17 differentiation in human autoimmune thyroid disorders. J Clin Endocrinol Metabol 100:E1531–E1539

    Article  Google Scholar 

  39. Mobarrez F, Abraham-Nordling M, Aguilera-Gatica K, Friberg I, Antovic A, Pisetsky DS, Jörneskog G, Wallen H (2016) The expression of microvesicles in the blood of patients with Graves’ disease and its relationship to treatment. Clin Endocrinol (Oxf) 84:729–735

    Article  CAS  Google Scholar 

  40. Vlasov P, Doi SQ, Sellitti DF (2016) FRTL-5 Rat Thyroid cells release thyroglobulin sequestered in exosomes: a possible novel mechanism for thyroglobulin processing in the thyroid. J Tyroid Res 2016:9276402

    Google Scholar 

  41. Marinò M, McCluskey RT (2000) Role of thyroglobulin endocytic pathways in the control of thyroid hormone release. Am J Physiol Cell Physiol 279:C1295–C1306

    Article  PubMed  Google Scholar 

  42. Botta R, Lisi S, Pinchera A, Taddei AR, Fausto AM, Giorgi F, Marinò M (2011) Binding, uptake, and degradation of internalized thyroglobulin in cultured thyroid and non-thyroid cells. J Endocrinol Invest 34:515–520

    CAS  PubMed  Google Scholar 

  43. Lisi S, Botta R, Rotondo Dottore G, Leo M, Latrofa F, Vitti P, Marinò M (2016) Intracellular retention of thyroglobulin in the absence of the low-density lipoprotein receptor-associated protein (RAP) is likely due to premature binding to megalin in the biosynthetic pathway. J Endocrinol Invest 39:1039–1044

    Article  CAS  PubMed  Google Scholar 

  44. Botta R, Lisi S, Rotondo Dottore G, Vitti P, Marinò M (2017) Binding of thyroglobulin (Tg) to the low-density lipoprotein receptor-associated protein (RAP) during the biosynthetic pathway prevents premature Tg interactions with sortilin. J Endocrinol Invest. doi: 10.1007/s40618-017-0668-0. (Epub ahead of print)

  45. Hakulinen J, Sankkila L, Sugiyama N, Kaisa Lehti K, Keski-Oja J (2008) Secretion of active membrane type 1 matrix metalloproteinase (MMP-14) into extracellular space in microvesicular exosomes. J Cell Biochem 105:1211–1218

    Article  CAS  PubMed  Google Scholar 

  46. Raposo G, Stoorvogel W (2013) Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 200:373–383

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Masci VL, Taddei AR, Gambellini G, Giorgi F, Fausto AM (2016) Microvesicles shed from fibroblasts act as metalloproteinase carriers in a 3D collagen matrix. J Circ Biomark 5:1–11

    Article  Google Scholar 

  48. Dahlman T, Grimelius L, Wallin G, Rubin K, Westermark K (1998) Integrins in thyroid tissue: upregulation of a2b1 in anaplastic thyroid carcinoma. Eur J Endocrinol 138:104–112

    Article  CAS  PubMed  Google Scholar 

  49. Cayrol F, Díaz Flaqué MC, Fernando T, Yang SN, Sterle HA, Bolontrade M, Amorós M, Isse B, Farías RN, Ahn H, Tian YF, Tabbò F, Singh A, Inghirami G, Cerchietti L, Cremaschi GA (2015) Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells. Blood 125:841–851

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Davies TF, Latif R (2015) Targeting the thyroid-stimulating hormone receptor with small molecule ligands and antibodies. Expert Opin Ther Targets 19:835–847

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Tan L, Wu H, Liu Y, Zhao M, Li D, Lu Q (2016) Recent advances of exosomes in immune modulation and autoimmune diseases. J Autoimmun 49:357–365

    Article  CAS  Google Scholar 

  52. Gallo A, Tandon M, Alevizos I, Illei GG (2012) The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One 7(3):e30679

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Isola AL, Chen S (2016) Exosomes: the link between GPCR activation and metastatic potential? Front Genet 7:56

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Maggio.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to disclose.

Ethical approval

This study does not involve human participants and/or animals.

Informed consent

For this type of study formal consent is not required.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rossi, M., Taddei, A.R., Fasciani, I. et al. The cell biology of the thyroid-disrupting mechanism of dichlorodiphenyltrichloroethane (DDT). J Endocrinol Invest 41, 67–73 (2018). https://doi.org/10.1007/s40618-017-0716-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-017-0716-9

Keywords

Navigation